Increasing sputum basophils is a marker for eosinophil-dominant airway inflammation in adult asthma Source: International Congress 2018 – Airway disease: recent discoveries Year: 2018
IPL576,092 reduces allergen-induced late asthmatic responses, sputum eosinophilia and airway hyperresponsiveness in mild asthma Source: Eur Respir J 2003; 22: Suppl. 45, 104s Year: 2003
Galectn-3 : marker of airway inflammation in bronchial asthma Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018
Induced sputum and airway inflammation in asthma and COPD Source: Annual Congress 2006 - PG14 - Noninvasive monitoring of asthma inflammation and treatment Year: 2006
Analysis of airway inflammation in allergic subjects with asymptomatic increased airway response to methacholine Source: Eur Respir J 2006; 28: Suppl. 50, 678s Year: 2006
Sputum eosinophilia, airway hyperresponsiveness and airway narrowing in young adults with former asthma Source: Eur Respir J 2005; 26: Suppl. 49, 733s Year: 2005
Markers of inflammation and airway responses to allergen in asthmatic patients Source: Annual Congress 2008 - Asthma: growing understanding of influential factors Year: 2008
Disconnect between sputum neutrophils and other measures of airway inflammation in asthma Source: Eur Respir J 2014; 43: 627-629 Year: 2013
Interleukin-17 in induced sputum correlates with airway hyperresponsiveness to methacholine Source: Eur Respir J 2001; 18: Suppl. 33, 193s Year: 2001
Sputum CC-chemokines, IL-13 and pulmonary function in allergic asthmatic children Source: Eur Respir J 2004; 24: Suppl. 48, 396s Year: 2004
Correlation of bronchoalveolar lavage eosinophil and mast cell activation with bronchial hyperresponsiveness in children with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 379s Year: 2002
Markers of airway inflammation and airway hyperresponsiveness in patients with well-controlled asthma Source: Eur Respir J 2001; 18: 444-450 Year: 2001
Effects of salmeterol/fluticasone propionate (SFC) on airway inflammation in induced sputum in COPD Source: Annual Congress 2005 - Effects of anti-inflammatory drugs on COPD Year: 2005
Bronchial hyperreactivity and airway inflammatory markers in nonasthmatic rhinitis Source: Eur Respir J 2003; 22: Suppl. 45, 476s Year: 2003
Sputum eosinophilia vs exhaled NO as markers of airways inflammation in asthma: relationship with asthma control Source: Eur Respir J 2005; 26: Suppl. 49, 736s Year: 2005
Increased arginase activity contributes to airway remodelling in chronic allergic asthma Source: Eur Respir J 2011; 38: 318-328 Year: 2011
Markers of airway inflammation and airway hyperresponsiveness remain stable in untreated asthmatics over time Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011
Corticosteroid-resistant neutrophilic airway inflammation and hyperresponsiveness caused by IL-13 Source: International Congress 2018 – Identification of therapeutic targets for asthma Year: 2018
Corticosteroid increased apoptosis of airway sputum macrophages from patients with COPD and emphysema Source: Eur Respir J 2001; 18: Suppl. 33, 337s Year: 2001
Cytokine-status in allergic airway inflammation provoked by latex Source: Eur Respir J 2002; 20: Suppl. 38, 511s Year: 2002